You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML in elderly

Showing 1 - 25 of 7,937
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023

Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Azacitidine and Venetoclax
  • Aurora, Colorado
    University of Colorado Denver
Aug 1, 2022

Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • AML Stage, Adult
  • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
  • Xiamen, Fujian, China
    Bing Xu
Oct 29, 2022

Acute Myeloid Leukemia Trial (Sulfasalazine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Oct 11, 2022

Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Milano, Lombardia, Italy
    Ospedale San Raffaele
Jul 18, 2022

Acute Myeloid Leukemia Trial in Tianjin ((cytarabine: daunorubicin) liposome for injection, Vyxeos)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (cytarabine: daunorubicin) liposome for injection
  • Vyxeos
  • Tianjin, China
    Institute of Hematology and Hospital of Blood Disease, Chinese A
Mar 24, 2023

AML Trial (APVO436)

Withdrawn
  • AML
  • APVO436
  • (no location specified)
Nov 29, 2021

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in Combination With Azacitidine and HA Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in Combination With Azacitidine and HA Regimen
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Jul 10, 2023

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Acute Myelogenous Leukemia (AML) Trial in Philadelphia (Eltrombopag)

Terminated
Has Results
  • Acute Myelogenous Leukemia (AML)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 14, 2021

Acute Myeloid Leukemia in Remission Trial in Nanjing (Azacitidine, Lenalidomide)

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022

AML, Adult, MDS Trial in Lørenskog (Standard therapy, Precision therapy)

Recruiting
  • AML, Adult
  • MDS
  • Standard therapy
  • Precision therapy
  • Lørenskog, Norway
    Akershus Universitetssykehus
Aug 23, 2021

Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
  • Venetoclax-Decitabine/Azacitidine Association
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022

Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,

Not yet recruiting
  • Essential Hypertension
  • Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
  • Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
  • Seoul, Gyeonggi-do, Korea, Republic of
  • +11 more
Sep 11, 2023

Acute Myeloid Leukemia Trial in Italy (Venetoclax and Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax and Decitabine
  • San Giovanni Rotondo, Foggia, Italy
  • +24 more
Aug 8, 2022

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Philadelphia, Houston (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
May 18, 2021

Acute Myeloblastic Leukemia Trial in Germany (sodium chloride solution 0.9%, temsirolimus)

Completed
  • Acute Myeloblastic Leukemia
  • Berlin, Germany
  • +4 more
Nov 10, 2021

AML, Recurrent, Refractory Trial in Jinan (Allogeneic NK cell regimen group)

Not yet recruiting
  • AML
  • +3 more
  • Allogeneic NK cell regimen group
  • Jinan, Shandong, China
    The 2nd Hospital of Shandong University
Oct 21, 2020

Acute Myeloid Leukemia Trial in Italy (Vidaza 100 milligram (mg) injection, Best Supportive Care)

Completed
  • Acute Myeloid Leukemia
  • Vidaza 100 milligram (mg) injection
  • Best Supportive Care
  • Alessandria, AL, Italy
  • +17 more
Jan 13, 2022

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 1, 2022

Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Decitabine,

Unknown status
  • Acute Myeloid Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Dec 18, 2020